Treatment of primary eosinophilic colitis using immunoglobulin/histamine complex

Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen‐specific antinociceptive effect in the treatment of histamine‐mediated pain.

Detalles Bibliográficos
Autores principales: Kim, Hyuk Soon, Noh, Geunwoong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9860130/
https://www.ncbi.nlm.nih.gov/pubmed/36698523
http://dx.doi.org/10.1002/ccr3.6885
Descripción
Sumario:Primary eosinophilic colitis (PEC) is a primary eosinophilic gastrointestinal disorder, and immunoglobulin/histamine complex (IHC) may be an effective therapeutic for PEC. IHC has a nonallergen‐specific antinociceptive effect in the treatment of histamine‐mediated pain.

Ejemplares similares